AWTTC - All Wales Therapeutics & Toxicology Centre

What AWTTC - All Wales Therapeutics & Toxicology Centre does

AWTTC (All Wales Therapeutics and Toxicology Centre) is a Welsh Special Health Authority within NHS Wales, headquartered in Cardiff and employing approximately 20 staff. Established in 2002, it operates as the single statutory advisory body coordinating specialist therapeutics, toxicology, and medicines optimization functions across the Welsh public health system. Its service portfolio is structured around several interconnected sub-services: medicines optimization guidance and data resources, the Yellow Card Centre Wales (adverse drug reaction reporting), the Welsh National Poisons Unit (poisoning emergency advice for clinicians), the Sodium Valproate Information Hub (medication safety for a high-risk drug), the Welsh Medicines Advice Service (expert medicines information for healthcare professionals), and the VPAG Programme supporting the UK's Voluntary Scheme for Branded Medicines Pricing, Access and Growth. Patient-facing content is delivered through the Your Medicines Your Health stream, with full bilingual (English/Cymraeg) coverage to serve Welsh-speaking populations.

The underlying technology stack is NHS Wales digital platform infrastructure, with the website built and maintained by Digital Health and Care Wales (DHCW); the input does not disclose proprietary software products, APIs, SDKs, or AI/ML systems. AWTTC delivers services through committee structures, health-board engagement, and bilingual digital content rather than commercial go-to-market motion.

AWTTC operates a non-commercial revenue model: services are provided free at the point of use as part of publicly funded NHS Wales healthcare, with no pricing tier, commercial contract structure, or external revenue disclosed. Its two primary customer segments are NHS Wales healthcare professionals (pharmacists, doctors, nurses, prescribers requiring medicines optimization and safety guidance) and Welsh patients and the public seeking medicines information. There is no evidence of named enterprise customers outside the NHS Wales system, no commercial partnerships, no awards, no patents, and no leadership or M&A activity in the input.

Name

AWTTC - All Wales Therapeutics & Toxicology Centre

Legal name

All Wales Therapeutics and Toxicology Centre

Website

https://awttc.org

Company type

Public

Operating status

Operating

Headcount range

11–50 employees

Short description

AWTTC is a Welsh Special Health Authority within NHS Wales that coordinates specialist therapeutics, toxicology, and medicines optimization advisory services for NHS Wales healthcare professionals and Welsh patients, delivered bilingually and free at the point of use.

Ownership category

akta.pro rank

Product category

Pharmaceutical Advisory Services

NAICS

Other Scientific and Technical Consulting Services (541690)

SIC

Services-Misc Health & Allied Services, Nec (8090)

akta.pro industry

PRIMARYHLAGALAC

Signal Detection & Safety Analytics (Epidemiology/RWE)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Pharmacovigilance & Medical Affairs Services

SECONDARYHLAGAOAF

Pharmacovigilance, Drug Safety & Risk Management FSP

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

Keywords

• Medicines optimisation
• Pharmacovigilance services
• Poisons information
• Therapeutics advisory
• Medicines safety

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Distribution channels1 record

Marketing channels3 records

Core offering

AWTTC is the Welsh NHS specialist centre providing medicines optimisation, pharmacovigilance, and toxicology advisory services across NHS Wales. It coordinates adverse drug reaction reporting through the Yellow Card Centre Wales, delivers poisons information and emergency toxicology advice via the Welsh National Poisons Unit, and publishes medicines safety guidance including resources on high-risk medicines such as sodium valproate. It also runs the VPAG Programme for branded medicines pricing and access schemes and supports the Welsh Medicines Advice Service.

Product overview

AWTTC is a Welsh NHS advisory body providing a unified portfolio of medicines-related services rather than a single commercial product. The centre operates through interconnected service areas including Accessing Medicines (guidance on medicine availability), Medicines Optimisation and Safety (with sub-components like the Yellow Card Centre Wales for adverse drug reaction reporting, Welsh National Poisons Unit for poisoning emergencies, and Sodium Valproate Information Hub for specific medication safety), plus the VPAG Programme for branded medicines pricing schemes. The Welsh Medicines Advice Service provides supplementary expert medicines information. These services collectively support NHS Wales in therapeutics, toxicology, and medication safety.

Differentiator

Problem solved

Functional benefit

Products and services

• Accessing Medicines

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves4 records

Expansion highlights3 records

Broad incumbents

• Department of Health and Social Care (UK): UK government department overseeing health policy and NHS England. Comparable as the ultimate policy authority that sets the framework within which AWTTC operates, with responsibility for the VPAG Programme and broader medicines pricing policy.
• National Institute for Health and Care Excellence (NICE): UK-wide body providing medicines guidance, technology appraisals, and clinical guidelines. Comparable to AWTTC in its medicines advisory function but operates at national UK scale with broader clinical remit, whereas AWTTC covers Wales.
• Medicines and Healthcare products Regulatory Agency (MHRA): UK regulator overseeing medicines safety, pharmacovigilance, and adverse drug reaction reporting. Directly comparable to AWTTC's Yellow Card Centre Wales activity, but at national regulatory authority scale.

Direct peers

• Scottish Medicines Consortium (SMC): Scotland's equivalent national body for medicines evaluation, advice, and access decisions. Highly comparable to AWTTC as a devolved-nation medicines advisory organization with parallel scope but Scottish-only geographic remit.
• National Poisons Information Service (NPIS): UK-wide poisons information service delivered through multiple regional units. AWTTC's Welsh National Poisons Unit is a regional constituent of NPIS, making it a direct peer in toxicology advisory services.
• Health Technology Wales (HTW): Welsh national health technology assessment body that evaluates non-medicine technologies and produces guidance for NHS Wales. Directly comparable as a fellow Welsh Special Health Authority producing national guidance within Wales.
• All Wales Medicines Strategy Group (AWMSG): Welsh health body providing strategic advice on medicines optimization and prescribing. Closely comparable as a fellow NHS Wales advisory body operating within the same Welsh health system with overlapping medicines guidance mandate.

Regional players

• Guy's and St Thomas' NHS Foundation Trust – Medicines Information Service: Major NHS medicines information service comparable to AWTTC's Welsh Medicines Advice Service. Functions as a regional/national medicines advice hub, though embedded within an NHS Foundation Trust rather than operating as a standalone Special Health Authority.

Emerging players

• UK Teratology Information Service (UKTIS): UK service providing advice on drug exposure in pregnancy, comparable to AWTTC's Sodium Valproate Information Hub. Both focus on medication safety in vulnerable populations, though UKTIS is national and AWTTC valproate hub is Wales-specific.
• NIHR Medicines for Children Research Network: UK-wide network supporting medicines research and pediatric pharmacology. Comparable to AWTTC's medicines research mandate within NHS Wales, though focused on children and clinical trials rather than general pharmacovigilance.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/all-wales-therapeutics-toxicology-centre

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AWTTC - All Wales Therapeutics & Toxicology Centre